Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
C$0.00
C$1.66
C$4.85
C$553.23MN/A669,999 shs1.96 million shs
McEwen Inc. stock logo
MUX
McEwen
$10.65
+2.4%
$10.08
$6.38
$11.80
$561.47M0.88765,798 shs755,549 shs
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
C$0.16
C$0.15
C$0.17
C$139.86MN/A1.82 million shsN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$47.20
-3.3%
$68.43
$46.90
$139.74
$217.94B0.6320.02 million shs21.39 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00%0.00%0.00%0.00%0.00%
McEwen Inc. stock logo
MUX
McEwen
+2.45%-0.33%-6.25%+36.21%+29.58%
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
0.00%0.00%0.00%0.00%0.00%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-3.39%-12.55%-31.64%-30.07%-62.54%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
2.1679 of 5 stars
3.61.00.00.03.10.80.6
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
N/AN/AN/AN/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4.1722 of 5 stars
3.05.02.50.02.90.03.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00
N/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
3.20
Buy$14.8339.35% Upside
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
0.00
N/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$93.6798.45% Upside

Current Analyst Ratings Breakdown

Latest NMX, KDX, NVO, and MUX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/5/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
7/31/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/31/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$57.00
7/30/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight
7/29/2025
McEwen Inc. stock logo
MUX
McEwen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.50 ➝ $17.00
7/16/2025
McEwen Inc. stock logo
MUX
McEwen
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
7/1/2025
McEwen Inc. stock logo
MUX
McEwen
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$12.00 ➝ $15.00
6/24/2025
McEwen Inc. stock logo
MUX
McEwen
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/9/2025
McEwen Inc. stock logo
MUX
McEwen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $15.50
(Data available from 8/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
$174.48M3.29N/AN/A$9.35 per share1.14
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
N/AN/AN/A3.11C$0.15 per shareN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$42.12B5.00$3.77 per share12.51$4.66 per share10.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/A0.00N/AN/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
-$43.69M-$0.57N/AN/AN/A-17.51%-6.03%-4.37%8/7/2025 (Estimated)
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
N/A-C$0.54N/AN/AN/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$14.64B$3.3813.9610.131.4834.52%80.94%24.23%8/6/2025 (Estimated)

Latest NMX, KDX, NVO, and MUX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
McEwen Inc. stock logo
MUX
McEwen
$0.09N/AN/AN/A$49.05 millionN/A
8/6/2025Q2 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.89N/AN/AN/A$77.51 billionN/A
5/7/2025Q1 2025
McEwen Inc. stock logo
MUX
McEwen
-$0.14-$0.12+$0.02-$0.12$39.06 million$35.70 million
5/7/2025Q1 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.92$0.92N/A$0.92N/A$11.87 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
N/AN/AN/AN/AN/A
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.643.47%N/A48.52%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
0.26
2.35
1.89
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
6.90
0.26
0.15
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.70
0.74
0.56

Institutional Ownership

CompanyInstitutional Ownership
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
McEwen Inc. stock logo
MUX
McEwen
17.03%
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
McEwen Inc. stock logo
MUX
McEwen
16.10%
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A180.21 millionN/ANot Optionable
McEwen Inc. stock logo
MUX
McEwen
43053.99 million45.30 millionOptionable
Nemaska Lithium Inc. stock logo
NMX
Nemaska Lithium
131847.63 millionN/ANot Optionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
77,3494.47 billion4.46 billionOptionable

Recent News About These Companies

Novo Nordisk weight loss injection
Novo Nordisk Stock Sinks—But Is a Bottom Finally In?
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Klondex Mines stock logo

Klondex Mines TSE:KDX

Klondex Mines Ltd., together with its subsidiaries, acquires, explores, develops, and produces mineral properties in the United States and Canada. It primarily explores for gold and silver deposits. The company holds 100% interests in the Fire Creek mine covering approximately 19,000 acres located in Lander County; the Midas mine and ore milling facility covering approximately 30,000 acres situated in Elko County; and the Hollister mine approximately 18,000 acres located in Elko County. It also has 100% interests in the True North gold mine and mill covering approximately 39,868 hectares situated in Manitoba, Canada; and the Aurora mine and ore milling facility covering approximately 5,004 contiguous acres located in Nevada, as well as in the Ogama-Rockland property in Manitoba, Canada. The company was formerly known as Attila Resources Limited and changed its name to Klondex Mines Ltd. in October 1974. Klondex Mines Ltd. was founded in 1971 and is headquartered in Reno, Nevada.

McEwen stock logo

McEwen NYSE:MUX

$10.64 +0.25 (+2.36%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$10.64 0.00 (-0.05%)
As of 08/5/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McEwen Mining Inc. engages in the exploration, development, production, and sale of gold and silver. It also explores for copper deposits. The company owns 100% interests in the El Gallo and Fenix projects located in Mexico; and the Black Fox Mine and Stock Mill, Grey Fox, and Froome and Tamarack properties in Canada. It also owns interests in the Fuller, Davidson-Tisdale, Buffalo Ankerite, and Paymaster exploration properties located in Canada; and a 49% interest in the San José mine located in Argentina. In addition, the company owns 100% interests in the Gold Bar and Tonkin properties located in Eureka County, Nevada; and interests in the Los Azules copper project located in the cordilleran region in the province of San Juan, Argentina. The company was formerly known as US Gold Corporation and changed its name to McEwen Mining Inc. in January 2012. McEwen Mining Inc. was founded in 1979 and is headquartered in Toronto, Canada.

Nemaska Lithium stock logo

Nemaska Lithium TSE:NMX

Nemaska Lithium Inc. operates as a developing chemical company in Canada. The company focuses on integrating activities from spodumene mining to the commercialization of lithium hydroxide and lithium carbonate. It owns 100% interests in the Whabouchi property that consists of 35 claims covering an area of 1,632.24 hectares located in the Eeyou Istchee/James Bay area of Quebec province. The company was formerly known as Nemaska Exploration Inc. and changed its name to Nemaska Lithium Inc. in November 2011. Nemaska Lithium Inc. was incorporated in 2007 and is headquartered in Quebec City, Canada.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$47.20 -1.61 (-3.30%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$47.39 +0.19 (+0.39%)
As of 08/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.